Tinidazole/miconazole nitrate/neomycin self-microemulsion soft capsules for vagina and preparation method thereof

A technology of miconazole nitrate and neomycin sulfate, which is applied in the directions of capsule delivery, medical preparations containing active ingredients, pharmaceutical formulations, etc. Guaranteed stability and scientific effect of formulation

Inactive Publication Date: 2013-06-19
SHENYANG PHARMA UNIVERSITY
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, both tinidazole and miconazole nitrate have suppositories on the market, but neomycin sulfate has not been used in suppositories, and there are no related reports on the joint preparation of the three into self-microemulsifying capsule preparations for vaginal use

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tinidazole/miconazole nitrate/neomycin self-microemulsion soft capsules for vagina and preparation method thereof
  • Tinidazole/miconazole nitrate/neomycin self-microemulsion soft capsules for vagina and preparation method thereof
  • Tinidazole/miconazole nitrate/neomycin self-microemulsion soft capsules for vagina and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Tinidazole 50mg

[0027] Miconazole Nitrate 10mg

[0028] Neomycin Sulfate 2mg

[0029] Medium Chain Triglycerides 102mg

[0030] Tween 80 75mg

[0031] Propylene Glycol 15mg

[0032] Mix the oil phase, emulsifier, and co-emulsifier, stir and mix evenly at 37°C, add the prescribed amount of tinidazole, miconazole nitrate, and neomycin sulfate, stir to dissolve completely, and mix well.

Embodiment 2

[0034] Tinidazole 25mg

[0035] Miconazole Nitrate 10mg

[0036] Neomycin Sulfate 1mg

[0037] Ethyl Oleate 70mg

[0038] Cremophor RH40 80mg

[0039] Ethanol 14mg

[0040] The preparation method is the same as in Example 1.

Embodiment 3

[0042] Tinidazole 50mg

[0043] Miconazole Nitrate 20mg

[0044] Neomycin Sulfate 2mg

[0045] soybean oil 78mg

[0046] Cremophor EL 91mg

[0047] Macrogol 400 18.2mg

[0048] The preparation method is the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of medicinal preparations, and relates to self-microemulsion soft capsules containing tinidazole / miconazole nitrate / neomycin for vagina and a preparation method thereof. The self-microemulsion soft capsules for the vagina consist of tinidazole, miconazole nitrate and neomycin sulfate in treatment effective dose, and can be used for multiple vaginitis. The methodfor preparing the self-microemulsion soft capsules comprises the following steps: heating surfactant, co-surfactant and oil phase to melt, adding the tinidazole, the miconazole nitrate and the neomycin sulfate in prescription amount into the melted mixture, and stirring the mixture till dissolving to obtain the self-microemulsion soft capsules. The self-microemulsion soft capsules prepared by themethod improve the bioavailability of the medicament in vivo, have quick response, and overcome the defect that the common vaginal tablets have lower bioavailability; and meanwhile, serving as a new composite dosage form, the formulation is scientific and novel and can provide a newer and better dosage form selection for both doctors and patients. The preparation process is simple and has no special requirement on preparation environment, the cost is low, the product quality is stable, and the preparation method is suitable for industrialized production.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, and relates to a tinidazole / miconazole nitrate / neomycin self-microemulsion soft capsule and a preparation method thereof. Background technique [0002] Tinidazole has anti-protozoa and obligate anaerobic effects, and has inhibitory effects on protozoa such as Trichomonas vaginalis, Entamoeba histolytica and Giardia lamblia, and has an inhibitory effect on most anorexia bacteria and Bacteroides fragilis , Bacteroides melanin, other Bacteroides, Clostridium, fungi, Fusobacterium, Haemophilus vaginalis, Peptococcus, Peptostreptococcus and Weschia cocci have inhibitory or killing effects. It is suitable for trichomonal vaginitis and bacterial vaginosis caused by sensitive anaerobic bacteria. There are currently unilateral suppository applications. [0003] Miconazole nitrate is a broad-spectrum antifungal drug, which has antibacterial effect on various fungi, especially Candida, and also ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7048A61K9/48A61K31/4164A61P15/02
Inventor 王东凯张晓君
Owner SHENYANG PHARMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products